Cycle Pharmaceuticals opens new headquarters
in Cambridge, UK

APRIL 15, 2016
Cycle Pharmaceuticals (Cycle) announced today the opening of its new headquarters in central Cambridge.  All employees have transferred to the new headquarters.
Antonio Benedetti, CEO of Cycle, commented: “Being located in central Cambridge is ideal for Cycle.  We are close to our University of Cambridge academic partners and our academic partners at the leading London universities.  Our new headquarters provides excellent space for Cycle to grow over the coming years.”
Cycle Pharmaceuticals new address is: Bailey Grundy Barrett Building, Little St Mary’s Lane, Cambridge CB2 1RR, UK.
Central office telephone number: +44 1223 354118
About Cycle Pharmaceuticals

Cycle Pharmaceuticals is a Cambridge-based pharmaceutical company that optimises and increases access to existing pharmaceuticals. Specifically, Cycle focuses on three areas of pharmaceutical development:

  • Improving orphan drugs, which treat the under-served rare disease patient community;
  • Reinstating drug products that have been previously marketed;
  • Working with our academic and other partners to extend pharmaceuticals to new medical areas where there is clear unmet need.

For further information, please visit www.cyclepharma.com